US pledges $2.1 billion to Glaxo, Sanofi for coronavirus vaccine

The U.S. government will pay $2.1 billion to the drugmakers Glaxo and Sanofi for the production of COVID-19 vaccines for up to 50 million people, tests and treatments, the companies announced Friday.It’s the largest grant that’s been given under the Trump administration’s “Operation Warp Speed,” the White House initiative focused on producing an accessible coronavirus vaccine by the end of the year. The deal covers 100 million vaccines, at two…